Rochester, MN, United States of America

Jia Yu


 

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations in Cancer Treatment by Inventor Jia Yu

Introduction

Jia Yu is an accomplished inventor based in Rochester, MN (US), known for his significant contributions to cancer treatment through innovative methods and materials. With a total of 2 patents, his work focuses on utilizing butyrylcholinesterases and USP7 polypeptide inhibitors to enhance cancer therapies.

Latest Patents

Jia Yu's latest patents include groundbreaking methods for using butyrylcholinesterases to treat various types of cancer, such as triple negative breast cancer and prostate cancer. These patents provide detailed methodologies for employing nucleic acid vectors to express BChE polypeptides, aiming to reduce cancer cell populations and growth rates in mammals. Additionally, he has developed methods that involve using USP7 polypeptide inhibitors to increase the sensitivity of cancer cells to treatments targeting CD340 polypeptides, particularly in cases of HER2 breast cancer that have shown resistance to trastuzumab.

Career Highlights

Jia Yu is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in cancer treatment. His innovative approaches have the potential to significantly impact the effectiveness of cancer therapies, providing new hope for patients.

Collaborations

Jia Yu collaborates with esteemed colleagues, including Liewei Wang and Judy C Boughey, who contribute to his research efforts in the field of oncology.

Conclusion

Jia Yu's innovative work in cancer treatment exemplifies the critical role of inventors in advancing medical science. His patents reflect a commitment to improving patient outcomes through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…